Single or mixed infections caused by ≥2 susceptible organisms; infections caused by organisms resistant to other antibiotics including aminoglycosides, penicillin & cephalosporins. Severe systemic (eg, septicaemia, bacteraemia, peritonitis, infections in immunosuppressed patients w/ haematological or solid tumors & in patients in ICU w/ specific problems eg, infected burns); resp tract (lobar & bronchopneumonia, acute & chronic bronchitis, acute exacerbation of cystic fibrosis, bronchiectasis, empyema); UTI (uncomplicated & complicated urethritis, cystitis, pyelonephritis, prostatitis, epididymitis); skin & soft tissue (eg, infected ulcers, wound infections, abscesses, cellulitis, otitis externa, erysipelas, infected burns); GI (eg, enteric fever, infective diarrhoea); biliary tract (eg, cholangitis, cholecystitis, gall bladder empyema); intra-abdominal (eg, peritonitis, intra-abdominal abscesses); bone & joint (eg, osteomyelitis, septic arthritis); pelvic (eg, salpingitis, endometritis, pelvic inflammatory diseases); & eye & ENT (eg, otitis media, sinusitis, mastoiditis, tonsilitis). Gonorrhoea including urethral, rectal & pharyngeal gonorrhoea caused by β-lactamase producing organisms or organisms moderately sensitive to penicillin.